Genomic Health's Q4 Revenues Rise 13 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market on Wednesday that revenues in the fourth quarter increased 13 percent year over year as the firm beat the consensus analyst estimates on the top and bottom lines.

The Mountain View, Calif.-based molecular diagnostic test development firm took in $60.4 million in revenues for the three months ended Dec. 31, 2012, compared to $53.4 million a year ago, topping the average Wall Street estimate of $58.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.